Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes.
about
Barriers to insulin progression among patients with type 2 diabetes: a systematic review.Web-based guided insulin self-titration in patients with type 2 diabetes: the Di@log study. Design of a cluster randomised controlled trial [TC1316].Correlates of insulin injection omissionFurther investigation of the psychometric properties of the Insulin Treatment Appraisal Scale among insulin-using and non-insulin-using adults with type 2 diabetes: results from Diabetes MILES-Australia.Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ)Validation of the Turkish version of the Centre for Epidemiologic Studies Depression Scale (CES-D) in patients with type 2 diabetes mellitus.Diabetes MILES--Australia (management and impact for long-term empowerment and success): methods and sample characteristics of a national survey of the psychological aspects of living with type 1 or type 2 diabetes in Australian adultsBarriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study.Diabetes MILES--The Netherlands: rationale, design and sample characteristics of a national survey examining the psychosocial aspects of living with diabetes in Dutch adults.Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration.Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.Adherence to treatment for diabetes mellitus: validation of instruments for oral antidiabetics and insulin.Development and validation of the Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) for primary care patients with type 2 diabetesValidation of the Turkish version of the problem areas in diabetes scaleGeographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc)Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot studyA systematic review of patient-reported measures of burden of treatment in three chronic diseasesBarriers to insulin treatment among Australian Torres Strait Islanders with poorly controlled diabetes.Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocolBenchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study: protocol, tools, and population.Cohort profiles of the cross-sectional and prospective participant groups in the second Diabetes MILES-Australia (MILES-2) study.Psychological resistance to insulin therapy in adults with type 2 diabetes: mixed-method systematic review.A short-acting GLP-1 analog or prandial insulin to supplement basal insulin?--Moving toward personalized management of type 2 diabetes mellitus.Translation and validation of the Insulin Treatment Appraisal Scale in Hong Kong primary care patients.Assessing Psychological Insulin Resistance in Type 2 Diabetes: a Critical Comparison of Measures.Cultural Differences and Considerations When Initiating Insulin.Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 8).The Barbados Insulin Matters (BIM) study: Barriers to insulin therapy among a population-based sample of people with type 2 diabetes in the Caribbean island of Barbados.Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study.Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care.Psycholosocial factors associated with psychological insulin resistance in primary care patients in Hong Kong.Acceptance of insulin therapy: a long shot? Psychological insulin resistance in primary care.Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore.Peer Education Group Intervention to Reduce Psychological Insulin Resistance: A Pilot Mixed-Method Study in a Chinese Population.Negative appraisals of insulin therapy are common among adults with Type 2 diabetes using insulin: Results from Diabetes MILES - Australia cross-sectional survey.Identification of barriers to insulin therapy and approaches to overcoming them.Resource utilisation and quality of life following initiation of insulin detemir in patients with type 2 diabetes mellitus.
P2860
Q31107413-9121C417-1480-477B-8522-2ABBAE874B49Q33464676-4EC5399D-0DDB-4941-B30B-86E48B3A03DDQ33602102-95562A81-B442-4C85-AC22-6511B7F4A3FFQ33729867-9A4D7C17-7962-4790-BFF5-938C6D5FF87CQ33797394-660636F6-E4CE-471E-B1B0-EE364895A774Q33972067-FED6F7AA-3156-42A3-8F8F-7069BEA6F61DQ34156176-AA9FC01D-4693-42B0-9168-A8B78BD78281Q34222009-F723903B-53DC-43F9-90CE-8866D3E60AB7Q34461286-0C962E35-7143-4428-88FA-3B1A6CBFE2D1Q34509377-A68685DC-006F-4460-A7A4-2A4E49DC3236Q34533154-6160E115-530D-4154-B00C-0037D4A2DC93Q34558840-2BF0ED48-6CFA-42E7-ADD1-044AEA61ED83Q34936273-F23C67F7-96EE-405C-88EC-7808A434DD5BQ35043641-D8553694-88A4-4428-BB6C-BB1796585B00Q35614989-7BD601F2-1B34-45AF-9B59-57B9C5BF57FCQ35768504-511251E9-63DB-4F05-992B-F7D26BE809A9Q36159008-8CB49746-DAD1-4C76-BAA8-D1ADA53B80D5Q36975806-FDE3D96D-8C99-4707-83EC-E52041D18328Q37561344-0A175785-815C-4278-9BB6-F88B6181FA90Q37595875-58EC39BA-8439-4AAE-98FF-83170FEBCD1FQ37603689-E4700847-C30E-4CAD-9D0F-23F1B9350620Q37681392-D06300A2-C05C-4B10-A820-BFA03BE3FEB6Q37952293-098B0C26-5319-4642-AF36-C8C8D754B252Q38219488-193674AA-FF68-4E7A-909D-F491886649A1Q38719949-214C18DA-5C69-4568-AD88-A99588607457Q39309460-0DF4A445-67A1-4F51-AA7A-53E09AD11855Q40955429-D730C9D2-7471-44BB-A559-C374E6EA0F38Q41100609-8503DEA3-D1FE-409F-882E-E1C22C8B99A3Q42656389-66C4F472-8FC9-48C9-A7A3-3EF460536BB2Q43328453-1C894967-6172-4187-B7F2-CEDB374A1D61Q43678513-1CB696C3-05B3-44C1-8490-1D6A7D157353Q45397334-4D95F47D-74CD-4CC9-A3FF-DBB38FD6F173Q45764893-5A653C88-99B8-47DF-8B3C-2147573AF16DQ45807463-27866F4D-FFBC-4E75-859F-A62D5A16648EQ47346547-E5C3FB0A-B4D6-4AB3-96C8-D4F4536A799CQ47744829-41E67E6F-0A93-4C49-82DB-A6B4CD892FEDQ48155086-A32A72DC-50A1-4BA2-9460-7E6AEA5CB0E4Q48202950-A583AEB3-CC42-4F40-9EA2-47B5A89C8679
P2860
Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Development and validation of ...... patients with type 2 diabetes.
@ast
Development and validation of ...... patients with type 2 diabetes.
@en
type
label
Development and validation of ...... patients with type 2 diabetes.
@ast
Development and validation of ...... patients with type 2 diabetes.
@en
prefLabel
Development and validation of ...... patients with type 2 diabetes.
@ast
Development and validation of ...... patients with type 2 diabetes.
@en
P2860
P356
P1476
Development and validation of ...... patients with type 2 diabetes
@en
P2093
Frank J Snoek
P2860
P2888
P356
10.1186/1477-7525-5-69
P577
2007-12-20T00:00:00Z
P5875
P6179
1033682562